/
IRTC
$118.95+$0.53 (+0.45%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$3.9B
33M shares
52-week range
$100.85 – $212.00
16% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Borrow rate
0.26%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$55.20
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $147.3M | $214.6M | $265.2M | $322.8M | $410.9M | $492.7M | $591.8M | $747.1M |
| Cost of revenue | $38.8M | $52.5M | $70.3M | $109.3M | $129.3M | $160.9M | $184.3M | $219.9M |
| Gross profit | $108.5M | $162.1M | $194.9M | $213.6M | $281.6M | $331.8M | $407.5M | $527.3M |
| Gross margin | 73.7% | 75.5% | 73.5% | 66.2% | 68.5% | 67.3% | 68.9% | 70.6% |
| R&D | $20.9M | $37.3M | $41.3M | $38.7M | $46.6M | $60.2M | $103.8M | $84.6M |
| Operating income | −$45.7M | −$54.8M | −$43.7M | −$99.9M | −$113.8M | −$125.2M | −$115.5M | −$36.8M |
| EBITDA | −$45.0M | −$49.4M | −$29.2M | −$83.2M | −$92.1M | −$96.9M | −$74.1M | −$4.0M |
| Net income | −$50.4M | −$54.6M | −$43.8M | −$101.4M | −$116.2M | −$123.4M | −$113.3M | −$44.6M |
| Net margin | -34.2% | -25.4% | -16.5% | -31.4% | -28.3% | -25.0% | -19.1% | -6.0% |
| EPS (diluted) | -2.02 | -2.16 | -1.58 | -3.46 | -3.88 | -4.04 | -3.63 | -1.39 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $881M | $-0.01 | $-0.02–$0.01 | 7 |
| 2027 | $1.0B | $1.11 | $0.87–$1.27 | 7 |
| 2028 | $1.2B | $2.27 | $2.05–$2.48 | 5 |
| 2029 | $1.4B | $4.10 | $4.05–$4.15 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$97.10
Price
$118.95
Implied downside
-18%
Peer comparison
iRhythm Holdings, Inc. Common Stock
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
www.irhythmtech.com- Employees
- 2,400
- IPO / List date
- Oct 20, 2016
- HQ
- San Francisco, CA
Held by traders on TradeandTell
No one on the platform currently holds IRTC.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 53,800 | $6.3M |
| Bridgewater Associatesas of 2025-12-31 | 11,348 | $2.0M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded IRTC yet.
